We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-14.41%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$36.6B
AUM Growth
-$4.36B
Cap. Flow
+$2.37B
Cap. Flow %
6.46%
Top 10 Hldgs %
9.54%
Holding
2,572
New
367
Increased
892
Reduced
1,066
Closed
238

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$352M
2
SBUX icon
Starbucks
SBUX
+$343M
3
META icon
Meta Platforms (Facebook)
META
+$312M
4
MCD icon
McDonald's
MCD
+$245M
5
EA icon
Electronic Arts
EA
+$225M

Sector Composition

Rank Sector Weight
1 Technology 16.92%
2 Consumer Discretionary 16.87%
3 Industrials 13.52%
4 Healthcare 11.98%
5 Consumer Staples 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MN
2226
DELISTED
MANNING & NAPIER, INC.
MN
$91K ﹤0.01%
51,839
-1,300
-2% -$2.69K
TLPH icon
2227
Talphera
TLPH
$70.1M
$89K ﹤0.01%
+1,927
New +$129K
AVAL icon
2228
Grupo Aval
AVAL
$5.67B
$88K ﹤0.01%
+14,900
New +$102K
EGY icon
2229
Vaalco Energy
EGY
$594M
$88K ﹤0.01%
59,806
+1,900
+3% +$3.63K
MFIN icon
2230
Medallion Financial
MFIN
$226M
$88K ﹤0.01%
18,757
-5,701
-23% -$34.9K
ARAV
2231
DELISTED
Aravive, Inc. Common Stock
ARAV
$87K ﹤0.01%
24,596
+113
+0.5% +$650
NNBR icon
2232
NN Inc
NNBR
$272M
$86K ﹤0.01%
+12,800
New +$123K
ORC
2233
Orchid Island Capital
ORC
$1.31B
$86K ﹤0.01%
+2,700
New +$89.9K
AHG
2234
Akso Health Group
AHG
$1.29B
$85K ﹤0.01%
+11,309
New +$186K
CTIC
2235
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$85K ﹤0.01%
115,483
+14,200
+14% +$23.3K
BGFV
2236
DELISTED
Big 5 Sporting Goods
BGFV
$83K ﹤0.01%
32,100
-13,267
-29% -$52.8K
DAIO icon
2237
Data I/O
DAIO
$32M
$82K ﹤0.01%
16,400
-500
-3% -$2.47K
ACGN
2238
DELISTED
Aceragen Inc
ACGN
$82K ﹤0.01%
1,743
+322
+23% +$37K
DS
2239
DELISTED
Drive Shack Inc.
DS
$81K ﹤0.01%
20,700
-4,079
-16% -$20.1K
MCRB icon
2240
Seres Therapeutics
MCRB
$48M
$78K ﹤0.01%
860
-80
-9% -$11.2K
TRIB
2241
Trinity Biotech
TRIB
$5.7M
$78K ﹤0.01%
227
CRR
2242
DELISTED
Carbo Ceramics Inc.
CRR
$77K ﹤0.01%
22,200
-3,405
-13% -$17K
INSG icon
2243
Inseego
INSG
$108M
$76K ﹤0.01%
1,830
-1,260
-41% -$46.7K
EPZM
2244
DELISTED
Epizyme, Inc
EPZM
$76K ﹤0.01%
+12,400
New +$94.7K
HBIO icon
2245
Harvard Bioscience
HBIO
$27.1M
$75K ﹤0.01%
2,346
-240
-9% -$9.46K
NGNE icon
2246
Neurogene
NGNE
$696M
$74K ﹤0.01%
1,715
+1,040
+154% +$50.7K
SBT
2247
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$74K ﹤0.01%
10,600
-2,400
-18% -$22.5K
BLCM
2248
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$73K ﹤0.01%
+2,500
New +$111K
NPTN
2249
DELISTED
NEOPHOTONICS CORP
NPTN
$73K ﹤0.01%
+11,300
New +$86.4K
SHLO
2250
DELISTED
Shiloh Industries Inc
SHLO
$73K ﹤0.01%
12,589
-2,911
-19% -$23.2K

Similar funds

Two Sigma Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, Two Sigma Advisers held 2,572 positions worth $36.6B, down 11% from $41B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Two Sigma Advisers deployed $2.37B of net new capital in Q4 2018, opening 367 new positions and adding to 892 existing holdings. Its largest new stake was Starbucks: 5,478,202 shares worth $353M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $274M trimmed.

  • Two Sigma Advisers's largest Q4 2018 buy was Starbucks: 5,478,202 shares worth $353M.
  • Two Sigma Advisers added most to SLB Ltd in Q4 2018, an estimated $352M increase.
  • Two Sigma Advisers's biggest Q4 2018 reduction was Alphabet (Google) Class A, cutting an estimated $274M.
  • Two Sigma Advisers fully exited Amazon in Q4 2018, selling an estimated $599M.
  • Two Sigma Advisers's ten largest holdings make up 9.5% of its $36.6B portfolio in Q4 2018.
  • Two Sigma Advisers opened 367 new positions and closed 238 in Q4 2018.
  • Two Sigma Advisers's portfolio value fell 11% quarter-over-quarter to $36.6B.

Based on Two Sigma Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.